GACM
Global Alpha Capital Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Buy |
79,460
+22,374
| +39% | +$535K | 0.12% | 51 |
|
|
2025
Q1 | $1.42M | Buy |
57,086
+17,186
| +43% | +$427K | 0.1% | 54 |
|
|
2024
Q4 | $752K | Buy |
39,900
+2,160
| +6% | +$40.7K | 0.05% | 56 |
|
|
2024
Q3 | $568K | Sell |
37,740
-49,560
| -57% | -$746K | 0.04% | 57 |
|
|
2024
Q2 | $2.5M | Buy |
87,300
+11,500
| +15% | +$329K | 0.18% | 42 |
|
|
2024
Q1 | $2.21M | Buy |
75,800
+3,300
| +5% | +$96.4K | 0.16% | 41 |
|
|
2023
Q4 | $2.45M | Buy |
+72,500
| New | +$2.45M | 0.2% | 37 |
|